Comparison
Why is ImmunoPrecise Antibodies Ltd. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
The company has declared negative results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at USD -9.09 MM
- NET SALES(Q) At USD 3 MM has Fallen at -38.86%
- NET PROFIT(Q) At USD -2.82 MM has Fallen at -85.52%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -32.28%, its profits have fallen by -19%
4
Below par performance in long term as well as near term
- Along with generating -32.28% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ImmunoPrecise Antibodies Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ImmunoPrecise Antibodies Ltd.
-29.19%
0.21
109.85%
S&P 500
22.36%
1.63
13.19%
Quality key factors
Factor
Value
Sales Growth (5y)
0.48%
EBIT Growth (5y)
-170.33%
EBIT to Interest (avg)
-11.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.66
Tax Ratio
9.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.51%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.55
EV to EBIT
-4.58
EV to EBITDA
-5.64
EV to Capital Employed
39.91
EV to Sales
3.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-871.14%
ROE (Latest)
-87.91%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
3What is working for the Company
NET PROFIT(HY)
Higher at USD -5.65 MM
RAW MATERIAL COST(Y)
Fallen by -4.71% (YoY
-34What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -9.09 MM
NET SALES(Q)
At USD 3 MM has Fallen at -38.86%
NET PROFIT(Q)
At USD -2.82 MM has Fallen at -85.52%
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.95 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.69 times
OPERATING PROFIT(Q)
Lowest at USD -2.98 MM
PRE-TAX PROFIT(Q)
Lowest at USD -3.09 MM
Here's what is working for ImmunoPrecise Antibodies Ltd.
Raw Material Cost
Fallen by -4.71% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ImmunoPrecise Antibodies Ltd.
Net Sales
At USD 3 MM has Fallen at -38.86%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -3.09 MM has Fallen at -131.04%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -2.82 MM has Fallen at -85.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -9.09 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD -2.98 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -3.09 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Inventory Turnover Ratio
Lowest at 4.95 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 3.69 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






